News

Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...
Bavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population ...
A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...
Hundreds of cases have been imported in recent months after an outbreak in Réunion. The disease is spread by tiger mosquitoes ...
Climate change is reshaping Europe’s disease landscape, with tropical mosquito-borne illnesses like dengue and chikungunya ...
UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...
COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV ...
Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year.The R ...
France confirms its first locally transmitted chikungunya case of 2025 in La Crau, Var, as health officials ramp up mosquito control efforts.
The UK’s Medicines and Healthcare products Regulatory Agency said that following global reports of serious adverse events in ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...